{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:42:41Z","timestamp":1760121761788},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,9,23]],"date-time":"2009-09-23T00:00:00Z","timestamp":1253664000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s12032-009-9297-6","type":"journal-article","created":{"date-parts":[[2009,9,21]],"date-time":"2009-09-21T18:15:38Z","timestamp":1253556938000},"page":"861-866","source":"Crossref","is-referenced-by-count":17,"title":["p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women"],"prefix":"10.1007","volume":"27","author":[{"given":"M. Meftah","family":"El khair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Ennaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"El kebbaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Ait","family":"Mhand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Attaleb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"El Mzibri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,23]]},"reference":[{"key":"9297_CR1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/jcp.2004.019315","volume":"58","author":"S Mitra","year":"2005","unstructured":"Mitra S, Misra C, Singh RK, Panda CK, Roychoudhury S. Association of specific genotype and haplotype of p53 gene with cervical cancer in India. J Clin Pathol. 2005;58:26\u201331.","journal-title":"J Clin Pathol"},{"key":"9297_CR2","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1126\/science.1659743","volume":"254","author":"H Zur Hausen","year":"1991","unstructured":"Zur Hausen H. Viruses in human cancers. Science. 1991;254:1167\u201373.","journal-title":"Science"},{"key":"9297_CR3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518\u201327.","journal-title":"N Engl J Med"},{"issue":"2","key":"9297_CR4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/gyno.2002.6735","volume":"86","author":"D Saranath","year":"2002","unstructured":"Saranath D, Khan Z, Tandle AT, Dedhia P, Sharma B, Contractor R, et al. HPV16\/18 prevalence in cervical lesions\/cancers and p53 genotypes in cervical cancer patients from India. Gynecol Oncol. 2002;86(2):157\u201362.","journal-title":"Gynecol Oncol"},{"key":"9297_CR5","doi-asserted-by":"crossref","first-page":"25729","DOI":"10.1074\/jbc.M401172200","volume":"279","author":"M Filippova","year":"2004","unstructured":"Filippova M, Parkhurst L, Duerksen-Hughes PJ. The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from fastriggered apoptosis. J Biol Chem. 2004;279:25729\u201344.","journal-title":"J Biol Chem"},{"issue":"1","key":"9297_CR6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3346\/jkms.2000.15.1.65","volume":"15","author":"WK Baek","year":"2000","unstructured":"Baek WK, Cho JW, Suh SI, Suh MH, Shin DH, Cho CH, et al. p53 codon 72 polymorphism and risk of cervical carcinoma in Korean women. Korean Med Sci. 2000;15(1):65\u20137.","journal-title":"Korean Med Sci"},{"key":"9297_CR7","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","volume":"63","author":"M Scheffner","year":"1990","unstructured":"Scheffner M, Werness BA, Huibregtse JM, et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990;63:1129\u201336.","journal-title":"Cell"},{"key":"9297_CR8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.2157286","volume":"248","author":"BA Werness","year":"1990","unstructured":"Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990;248:76\u20139.","journal-title":"Science"},{"key":"9297_CR9","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1128\/JVI.78.8.4063-4073.2004","volume":"78","author":"SM Horner","year":"2004","unstructured":"Horner SM, DeFilippis RA, Manuelidis L, et al. Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in HeLa cervical carcinoma cells. J Virol. 2004;78:4063\u201373.","journal-title":"J Virol"},{"issue":"3","key":"9297_CR10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35106009","volume":"1","author":"T Soussi","year":"2001","unstructured":"Soussi T, B\u00e9roud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer. 2001;1(3):233\u201340.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"9297_CR11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/MCB.7.2.961","volume":"7","author":"GJ Matlashewski","year":"1987","unstructured":"Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV. Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol. 1987;7(2):961\u20133.","journal-title":"Mol Cell Biol"},{"issue":"6682","key":"9297_CR12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/30400","volume":"393","author":"A Storey","year":"1998","unstructured":"Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature. 1998;393(6682):229\u201334.","journal-title":"Nature"},{"key":"9297_CR13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0890-8508(92)90059-7","volume":"6","author":"O Lungu","year":"1992","unstructured":"Lungu O, Wright TC Jr, Silverstein S. Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes. 1992;6:145\u201352.","journal-title":"Mol Cell Probes"},{"key":"9297_CR14","first-page":"175","volume":"10","author":"S Andersson","year":"2003","unstructured":"Andersson S, Rylander E, Larson B, Sigurdardottir S, Backlund I, Sallstrom J, et al. Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing. Oncol Rep. 2003;10:175\u20139.","journal-title":"Oncol Rep"},{"key":"9297_CR15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/B978-0-12-372180-8.50046-9","volume-title":"PCR protocols: a guide to methods and applications","author":"Y Ting","year":"1990","unstructured":"Ting Y, Manos MM. Detection and typing of genital human papillomaviruses. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. San diego: Academic press; 1990. p. 356\u201367."},{"key":"9297_CR16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.1991.03460040048027","volume":"256","author":"HM Bauer","year":"1991","unstructured":"Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro JC, Chimera CL, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 1991;256:472\u20137.","journal-title":"JAMA"},{"key":"9297_CR17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1386-6532(02)00227-5","volume":"27","author":"M Amrani","year":"2003","unstructured":"Amrani M, Lalaoui K, El Mzibri M, Lazo P, Alaoui Belabbas M. Molecular detection of human papillomavirus in 594 uterine cervix samples from Moroccan women (147 biopsies and 447swabs). J Clin Virol. 2003;27:286\u201395.","journal-title":"J Clin Virol"},{"key":"9297_CR18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000052925","volume":"51","author":"KW Lo","year":"2001","unstructured":"Lo KW, Cheung TH, Chung TK, Wang VW, Poon JS, Li JC, et al. Clinical and prognostic significance of human papillomavirus in a Chinese population of cervical cancers. Gynecol Obstet Invest. 2001;51:202\u20137.","journal-title":"Gynecol Obstet Invest"},{"issue":"4 Pt 2","key":"9297_CR19","first-page":"727","volume":"92","author":"J Melnikow","year":"1998","unstructured":"Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol. 1998;92(4 Pt 2):727\u201335.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"9297_CR20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cdp.2005.06.007","volume":"29","author":"A Koushik","year":"2005","unstructured":"Koushik A, Ghosh A, Duarte-Franco E, Forest P, Voyer H, Matlashewski G, et al. Biomarkers of cervical cancer risk (BCCR) Study Team. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. Cancer Detect Prev. 2005;29(4):307\u201316.","journal-title":"Cancer Detect Prev"},{"key":"9297_CR21","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1054\/bjoc.1999.0993","volume":"82","author":"N Hamel","year":"2000","unstructured":"Hamel N, Black MJ, Ghadirian P, Foulkes WD. No association between p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck. Br J Cancer. 2000;82:757\u20139.","journal-title":"Br J Cancer"},{"key":"9297_CR22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1054\/bjoc.2000.1674","volume":"84","author":"AT Tandle","year":"2001","unstructured":"Tandle AT, Sanghvi V, Saranath D. Determination of p53 genotypes in oral cancer patients from India. Br J Cancer. 2001;84:739\u201342.","journal-title":"Br J Cancer"},{"issue":"4","key":"9297_CR23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1590\/S1415-47572004000400005","volume":"27","author":"SM Brenna","year":"2004","unstructured":"Brenna SM, Silva ID, Zeferino LC, Pereira JS, Martinez EZ, Syrj\u00e4nen KJ. Prevalence of codon 72 P53 polymorphism in Brazilian women with cervix cancer. Genet Mol Biol. 2004;27(4):496\u20139.","journal-title":"Genet Mol Biol"},{"issue":"3","key":"9297_CR24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.21103","volume":"80","author":"S Oliveira","year":"2008","unstructured":"Oliveira S, Sousa H, Santos AM, Pinto D, Pinto-Correia AL, Fontoura D, et al. The p53 R72P polymorphism does not influence cervical cancer development in a Portuguese population: a study in exfoliated cervical cells. J Med Virol. 2008;80(3):424\u20139.","journal-title":"J Med Virol"},{"key":"9297_CR25","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1128\/MCB.19.2.1092","volume":"19","author":"M Thomas","year":"1999","unstructured":"Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol. 1999;19:1092\u2013100.","journal-title":"Mol Cell Biol"},{"key":"9297_CR26","first-page":"249","volume":"4","author":"NM Wang","year":"1999","unstructured":"Wang NM, Tsai CH, Yeh KT, et al. p53 codon 72Arg polymorphism is not a risk factor for carcinogenesis in the Chinese. Int J Mol Med. 1999;4:249\u201352.","journal-title":"Int J Mol Med"},{"key":"9297_CR27","first-page":"337","volume":"103","author":"MT Wu","year":"2004","unstructured":"Wu MT, Liu CL, Ho CK, et al. Genetic polymorphism of p53 and XRCC1 in cervical intraepithelial neoplasm in Taiwanese women. J Formos Med Assoc. 2004;103:337\u201343.","journal-title":"J Formos Med Assoc"},{"key":"9297_CR28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s001090050353","volume":"77","author":"R Klaes","year":"1999","unstructured":"Klaes R, Ridder R, Schaefer U, et al. No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer. J Mol Med. 1999;77:299\u2013302.","journal-title":"J Mol Med"},{"key":"9297_CR29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0301-2115(02)00006-4","volume":"103","author":"O Humbey","year":"2002","unstructured":"Humbey O, Aubin F, Cairey-Remonnay S, et al. TP53 polymorphism at exon 4 in Caucasian women from eastern France: lack of correlation with HPV status and grade of cervical precancerous lesions. Eur J Obstet Gynecol Reprod Biol. 2002;103:60\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"9131","key":"9297_CR30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(98)07357-7","volume":"352","author":"AN Rosenthal","year":"1998","unstructured":"Rosenthal AN, Ryan A, Al-Jehani RM, Storey A, Harwood CA, Jacobs IJ. p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet. 1998;352(9131):871\u20132.","journal-title":"Lancet"},{"key":"9297_CR31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1525-1438.2002.01109.x","volume":"12","author":"RJ Pegoraro","year":"2002","unstructured":"Pegoraro RJ, Rom L, Lanning PA, et al. p53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women. Int J Gynecol Cancer. 2002;12:383\u20138.","journal-title":"Int J Gynecol Cancer"},{"key":"9297_CR32","first-page":"1009","volume":"10","author":"SJ Klug","year":"2001","unstructured":"Klug SJ, Wilmotte R, Santos C, et al. TP53 polymorphism, HPV infection, and risk of cervical cancer. Cancer Epidemiol Biomarkers Prev. 2001;10:1009\u201312.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9297_CR33","first-page":"2161","volume":"20","author":"K Szarka","year":"2000","unstructured":"Szarka K, Veress G, Juhasz A, et al. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers. Anticancer Res. 2000;20:2161\u20137.","journal-title":"Anticancer Res"},{"key":"9297_CR34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00008469-200004000-00007","volume":"9","author":"T Agorastos","year":"2000","unstructured":"Agorastos T, Lambropoulos AF, Constantinidis TC, et al. p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women. Eur J Cancer Prev. 2000;9:113\u20138.","journal-title":"Eur J Cancer Prev"},{"issue":"6711","key":"9297_CR35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/25040","volume":"396","author":"A Hildesheim","year":"1998","unstructured":"Hildesheim A, Schiffman M, Brinton LA, Fraumeni JF Jr, Herrero R, Bratti MC, et al. p53 polymorphism and risk of cervical cancer. Nature. 1998;396(6711):531\u20132.","journal-title":"Nature"},{"issue":"1\u20132","key":"9297_CR36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0304-3835(02)00430-5","volume":"188","author":"P Bhattacharya","year":"2002","unstructured":"Bhattacharya P, Duttagupta C, Sengupta S. Proline homozygosity in codon 72 of p53: a risk genotype for human papillomavirus related cervical cancer in Indian women. Cancer Lett. 2002;188(1\u20132):207\u201311.","journal-title":"Cancer Lett"},{"issue":"4","key":"9297_CR37","first-page":"435","volume":"9","author":"P Tenti","year":"2000","unstructured":"Tenti P, Vesentini N, Rondo Spaudo M, Zappatore R, Migliora P, Carnevali L, et al. p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy. Cancer Epidemiol Biomarkers Prev. 2000;9(4):435\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9297_CR38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1744-313X.2007.00678.x","volume":"34","author":"VA Govan","year":"2007","unstructured":"Govan VA, Loubser S, Saleh D, Hoffman M, Williamson AL. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency. Int J Immunogenet. 2007;34:213\u20137.","journal-title":"Int J Immunogenet"},{"key":"9297_CR39","first-page":"731","volume":"20","author":"H Sousa","year":"2007","unstructured":"Sousa H, Santos AM, Pinto D, Medeiros R. Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations. Int J Mol Med. 2007;20:731\u201341.","journal-title":"Int J Mol Med"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9297-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-009-9297-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9297-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:22:40Z","timestamp":1559427760000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-009-9297-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,23]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9297"],"URL":"https:\/\/doi.org\/10.1007\/s12032-009-9297-6","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,23]]}}}